Recursion Pharmaceuticals(RXRX)
Focus: Recursion Pharmaceuticals is a public biotech company pioneering automated, software-based drug discovery platforms to accelerate identification and development of novel therapeutics. The company operates at the intersection of computational biology and traditional pharma, with early-stage clinical programs primarily in neurology and oncology.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
30-9 this month
Cooling — net -9 jobs in 30d
15 added, 24 removed. Slower than typical.
Should You Work at Recursion Pharmaceuticals?
AI assessmentRecursion is a high-risk, high-innovation opportunity suited for technologists and early-stage drug development professionals betting on AI-enabled discovery; traditional pharma operators should assess tolerance for extended pre-revenue phase and platform dependency.
Why Work Here
- Cutting-edge AI/ML-driven drug discovery platform offers rare exposure to computational pharma at clinical scale with 9 active trials across multiple therapeutic areas.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$45M
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT06980116Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1Help build intelligence for Recursion Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.